当前位置: X-MOL 学术Clin. Infect. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Large-scale Artemisinin–Piperaquine Mass Drug Administration With or Without Primaquine Dramatically Reduces Malaria in a Highly Endemic Region of Africa
Clinical Infectious Diseases ( IF 11.8 ) Pub Date : 2018-04-24 , DOI: 10.1093/cid/ciy364
Changsheng Deng 1 , Bo Huang 1 , Qi Wang 1, 2 , Wanting Wu 2 , Shaoqin Zheng 2 , Hongying Zhang 2 , Di Li 2 , Danghong Feng 2 , Guoming Li 2 , Linlu Xue 2 , Tao Yang 2 , Fei Tuo 2 , Fouad Mohadji 3 , Xin-Zhuan Su 4 , Qin Xu 1 , Zhibing Wu 5 , Li Lin 5 , Jiuyao Zhou 6 , Hong Yan 2 , Affane Bacar 7 , Kamal Said Abdallah 7 , Rachadi A Kéké 7 , Ahamada Msa Mliva 3 , Moussa Mohamed 3 , Xinhua Wang 8 , Shiguang Huang 9 , Fatihou Oithik 3 , Xiao-Bo Li 2 , Fangli Lu 10, 11 , Michael P Fay 12 , Xiao-Hong Liu 13 , Thomas E Wellems 4 , Jianping Song 1, 2
Affiliation  

Mass drug administration (MDA), with or without low-dose primaquine (PMQLD), is being considered for malaria elimination programs. The potential of PMQLD to block malaria transmission by mosquitoes must be balanced against liabilities of its use.

中文翻译:

有或没有伯氨喹的大规模青蒿素-哌喹大规模给药显着减少非洲高度流行地区的疟疾

大规模药物管理 (MDA),有或没有低剂量伯氨喹 (PMQ LD ),正在考虑用于消除疟疾计划。PMQ LD阻止蚊子传播疟疾的潜力必须与其使用的责任相平衡。
更新日期:2018-04-24
down
wechat
bug